The Efficacy of MK-8291 in Participants With Post-herpetic Neuralgia (PHN) With Allodynia (MK-8291-012)
Clinical trial NCT02336555 · COMPLETED
Trial details
- NCT number
- NCT02336555
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-12
- Primary completion
- 2016-02-29
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.